Matches in Nanopublications for { ?s ?p "[Here we show that NF-E2 expression is also increased in patients with essential thrombocythemia and primary myelofibrosis independent of the presence of the JAK2(V617F) mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP531293.RA7VKCG8s0RFcnAlB7l_28hSAsC14Sc_-EYa72flcBV9U130_assertion description "[Here we show that NF-E2 expression is also increased in patients with essential thrombocythemia and primary myelofibrosis independent of the presence of the JAK2(V617F) mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531293.RA7VKCG8s0RFcnAlB7l_28hSAsC14Sc_-EYa72flcBV9U130_provenance.
- NP588877.RAZomCqW10eXYaRXveSOIBjYXMaJcsc9Mmlpby8y3CORo130_assertion description "[Here we show that NF-E2 expression is also increased in patients with essential thrombocythemia and primary myelofibrosis independent of the presence of the JAK2(V617F) mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588877.RAZomCqW10eXYaRXveSOIBjYXMaJcsc9Mmlpby8y3CORo130_provenance.
- NP526102.RAJ7Z9UMo0eb9MPT8L1lPKYQgN14Om821nh2GyfqhLYA0130_assertion description "[Here we show that NF-E2 expression is also increased in patients with essential thrombocythemia and primary myelofibrosis independent of the presence of the JAK2(V617F) mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526102.RAJ7Z9UMo0eb9MPT8L1lPKYQgN14Om821nh2GyfqhLYA0130_provenance.
- assertion description "[Here we show that NF-E2 expression is also increased in patients with essential thrombocythemia and primary myelofibrosis independent of the presence of the JAK2(V617F) mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Here we show that NF-E2 expression is also increased in patients with essential thrombocythemia and primary myelofibrosis independent of the presence of the JAK2(V617F) mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP588907.RAx82Xt8tEpMO0CzNyIzHb4lFNYzsmqDx-LaNYs7Ga3lQ130_assertion description "[Here we show that NF-E2 expression is also increased in patients with essential thrombocythemia and primary myelofibrosis independent of the presence of the JAK2(V617F) mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588907.RAx82Xt8tEpMO0CzNyIzHb4lFNYzsmqDx-LaNYs7Ga3lQ130_provenance.
- NP802592.RA04NFEauJcydlW5de6EBb_0iI0CdMlg5_l2vWe_-Wt5U130_assertion description "[Here we show that NF-E2 expression is also increased in patients with essential thrombocythemia and primary myelofibrosis independent of the presence of the JAK2(V617F) mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802592.RA04NFEauJcydlW5de6EBb_0iI0CdMlg5_l2vWe_-Wt5U130_provenance.
- NP802596.RA3LOMGyXt19sITAyiEEZ6mLE6GCpIQzc6bJ6q27wZze0130_assertion description "[Here we show that NF-E2 expression is also increased in patients with essential thrombocythemia and primary myelofibrosis independent of the presence of the JAK2(V617F) mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802596.RA3LOMGyXt19sITAyiEEZ6mLE6GCpIQzc6bJ6q27wZze0130_provenance.